Novel immunotherapy improves recovery from spinal cord injury
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune cells.
Groves named head of developmental biology
Andy Groves, a leading researcher in the development of the inner ear, will head the Department of Developmental Biology at Washington University School of Medicine in St. Louis beginning in April.
Wahl honored for leadership in nuclear medicine and imaging
The Society of Nuclear Medicine and Molecular Imaging recently presented the 2024 Minoshima-Pappas Transformative Leadership Award to Richard Wahl, MD, a professor of radiology and of radiation oncology at WashU Medicine.
Vedantham honored for innovation in interventional radiology
Suresh Vedantham, MD, a professor of radiology and of surgery at Washington University School of Medicine in St. Louis, has been awarded the 2024 Leader in Innovation Award by the Society of Interventional Radiology Foundation.
Cooper named inaugural French professor
Megan Cooper, MD, PhD, of Washington University School of Medicine in St. Louis, has been named the inaugural Anthony R. French, MD, PhD, Professor in Pediatrics.
Zebrafish use surprising strategy to regrow spinal cord
Researchers at WashU Medicine look to zebrafish — among the rare vertebrates that can repair a damaged spinal cord — to understand how it might be possible to treat nerve injuries in people.
Blake essay recognized by Lasker Foundation
Kevin Blake, a scientific editor in the Department of Pathology & Immunology at Washington University School of Medicine in St. Louis, has been honored for an essay he wrote titled “Missing Microbiomes: Global Underrepresentation Restricts Who Research Will Benefit.”
DNA fragments help detect kidney organ rejection
Raja Dandamudi, MD, Vikas Dharnidharka, MD, and Tarek Alhamad, MD, all at Washington University School of Medicine in St. Louis, contributed to a large study that identified a novel way of detecting signs of organ rejection.
Potential drug effective against flesh-eating bacteria
Researchers at Washington University School of Medicine in St. Louis have developed a potential drug that is effective against common bacteria that can lead to rare, dangerous illnesses.
Nasal COVID-19 vaccine halts transmission
A nasal COVID-19 vaccine blocks transmission of the virus, according to an animal study by researchers at Washington University School of Medicine in St. Louis. The findings suggest that vaccines delivered directly to the nose or mouth could play a critical role in containing the spread of respiratory infections.
Older Stories